The methods comprise the step of administering to the patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait (a "therapeutic amount")
[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Crous-Bou M, Minguilln C, Gramunt N, Molinuevo JL
There is an urgent need for a pharmacological agent that can specifically and safely correct the shared metabolic pathology, ideally by acting at both central (e.g., controlling appetite and cravings) and peripheral (e.g., improving insulin sensitivity, reducing hepatic fat and inflammation) levels to support and enhance existing behavioral strategies, thereby lowering the risk of advanced liver disease development across metabolic and alcoholic etiologies
Kunak CS, Ugan RA, Cadirci E, Karakus E, Polat B, Un H, et al Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosis Br J Radiol
For many of us, if that bar of chocolate is going to be opened, then its going to be finished in one sitting